VTRS Q1 2019 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.5B-7.0% YoY

Gross Profit

$805M32.3% margin

Operating Income

$24M1.0% margin

Net Income

-$25M-1.0% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-18.9%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$93M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$31.9B

Total Liabilities

$20.0B

Stockholders' Equity

$11.9B

Cash & Equivalents

$230M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.5B	$2.7B	-7.0%
Gross Profit	$805M	$984M	-18.2%
Operating Income	$24M	$156M	-84.6%
Net Income	-$25M	$87M	-128.7%